POLITICOPRO Health Care:By Brianna Ehley
The FDA will soon require drug companies to study whether prescription opioids already on the market are effective in managing chronic pain, the Washington Post’s Lenny Bernstein and Laurie McGinley report. More.
Roni Caryn Rabin in the New York Times explores the popularity of CBD oil, despite little research on its long-term effects. More.
Colorado on Monday became the third state to receive CMS approval to negotiate drug prices for Medicaid based on their effectiveness and value, Modern Healthcare’s Robert King reports. More.
Today’s Finance Committee hearing shows how pharma has lost its edge in Washington, Bloomberg’s Cynthia Koons and Anna Edney write. More.
Measles outbreaks have spurred backlash against anti-vaccine advocates, and some states are considering measures to make it harder for parents to opt out of immunizing their children, the Washington Post’s Lena Sun reports. More.
